Abstract | BACKGROUND: QUESTIONS/PURPOSES: METHODS: Fifty patients who received a preoperative dose of aprepitant (study group) were matched demographically to 50 patients who did not receive aprepitant (control group) from a group of patients undergoing THA or TKA. Patients' charts were reviewed to identify episodes of PONV, number of doses of antiemetics needed for breakthrough PONV, and length of stay. Aprepitant side effects, and complications. RESULTS:
Aprepitant reduced the percentage of patients with PONV (39% of study and 70% of control patients). Moderate or severe PONV occurred in 22% of study and 40% of control patients. The number of episodes of PONV during hospitalization was 2.9 for the control group and 1.6 for the study group. Postoperatively, the control group required on average 1.3 doses of ondansetron compared with 0.6 doses for the study group. Hospital length of stay was reduced from 3.3 days for the control group and to 2.3 days for the study group. CONCLUSIONS: LEVEL OF EVIDENCE: Level II, prognostic study. See guidelines for authors for a complete description of levels of evidence.
|
Authors | Timothy M DiIorio, Peter F Sharkey, Agnes M Hewitt, Javad Parvizi |
Journal | Clinical orthopaedics and related research
(Clin Orthop Relat Res)
Vol. 468
Issue 9
Pg. 2405-9
(Sep 2010)
ISSN: 1528-1132 [Electronic] United States |
PMID | 20419358
(Publication Type: Journal Article)
|
Chemical References |
- Antiemetics
- Morpholines
- Aprepitant
- Ondansetron
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antiemetics
(administration & dosage, adverse effects)
- Aprepitant
- Arthroplasty, Replacement, Hip
(adverse effects)
- Arthroplasty, Replacement, Knee
(adverse effects)
- Case-Control Studies
- Drug Administration Schedule
- Female
- Humans
- Length of Stay
- Male
- Middle Aged
- Morpholines
(administration & dosage, adverse effects)
- Ondansetron
(administration & dosage)
- Postoperative Nausea and Vomiting
(prevention & control)
- Preoperative Care
- Retrospective Studies
- Severity of Illness Index
- Time Factors
- Treatment Outcome
|